Novo Nordisk Group General Counsel & Senior Vice President John Kuckelman speaks with Bloomberg's Dani Burger and Isabelle Lee after the company on Tuesday accused rival Eli Lilly of misleading advertising. Novo says that Lilly’s advertising campaigns rely on outdated weight-loss comparisons with lower doses of Novo’s own obesity shot Wegovy than what’s currently available, according to the complaint.

IMF Chief Kristalina Georgieva Talks US Economy, Kevin Warsh
13:44

Affirm CEO Max Levchin Talks Revenue Growth, Consumer Spending
07:54

Harvard's Ken Rogoff Talks US Debt, Fiscal Crisis Risks
07:36